Working… Menu

Neurotomy of Optic Nerve in Non-Arthritic Anterior Ischemic Optic Neuropathy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00372021
Recruitment Status : Completed
First Posted : September 6, 2006
Last Update Posted : October 12, 2006
Information provided by:
Shahid Beheshti University of Medical Sciences

Brief Summary:
Non-arthritic anterior ischemic optic neuropathy is the most common cause of sudden visual loss due to optic nerve involvement in patients above 50 years old. As this problem can be considered as a sclera out let syndrome an there is no effective and successful treatment for it, we decided to do a neurotomy procedure and relax the involved optic nerve in order to achieve acceptable treating outcome.

Condition or disease Intervention/treatment Phase
Non Arthritic Anterior Ischemic Optic Neuropathy Procedure: optic nerve neurotomy Phase 1 Phase 2

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single
Primary Purpose: Treatment
Study Start Date : January 2003

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   50 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Patients with non-arthritic anterior ischemic optic nerve

Exclusion Criteria:

  • Visual acuity more than 20/200
  • Other intra occular operations
  • Passing more than 4 weeks of the problem
  • Arthritic anterior ischemic optic nerve
  • Age under 50 years
  • Consumption of previous pharmaceutical treatment

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00372021

Layout table for location information
Iran, Islamic Republic of
Ophthalmic Research Center
Tehran, Iran, Islamic Republic of, 16666
Sponsors and Collaborators
Shahid Beheshti University of Medical Sciences
Layout table for investigator information
Principal Investigator: Masoud Soheilian, MD Ophthalmic Research Center of Shaheed Beheshti Medical University

Layout table for additonal information Identifier: NCT00372021     History of Changes
Other Study ID Numbers: 8136
First Posted: September 6, 2006    Key Record Dates
Last Update Posted: October 12, 2006
Last Verified: November 2002
Keywords provided by Shahid Beheshti University of Medical Sciences:
non arthritic ischemic optic neuropathy
anterior ischemic optic neuropathy
Optic nerve Neurotomy
Additional relevant MeSH terms:
Layout table for MeSH terms
Optic Nerve Diseases
Optic Neuritis
Optic Neuropathy, Ischemic
Pathologic Processes
Nervous System Diseases
Cranial Nerve Diseases
Eye Diseases
Vascular Diseases
Cardiovascular Diseases